iShares U.S. Pharmaceuticals ETF Rating $75.18 -0.02 (-0.03%) Closing price 10/8/2025 04:10 PM EasternExtended Trading$75.18 -0.01 (-0.01%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.61Holdings in IHE have an aggregate rating of Moderate Buy based on 283 analyst ratings issued in the past year covering 25 companies (95.8% of the portfolio).IHE Aggregate Price Target$75.18High Prediction$75.18Average Prediction$75.18Low Prediction$75.18Holdings in IHE have an aggregate price target of $75.18 and a range of $75.18 to $75.18 covering 25 companies (95.8% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings23.92%JNJJohnson & Johnson$189.75+0.5%4.6941 of 5 stars2.73$189.88 0.1%22Trending NewsUpcoming EarningsAnalyst Forecast20.12%LLYEli Lilly and Company$845.55+0.2%4.9928 of 5 stars2.64$943.00 11.5%25Trending NewsAnalyst Forecast4.68%VTRSViatris$9.97-1.7%1.678 of 5 stars1.67$10.40 4.3%6Analyst Forecast4.48%RPRXRoyalty Pharma$36.02-0.2%4.8521 of 5 stars3.20$46.00 27.7%5Analyst Upgrade4.42%ELANElanco Animal Health$20.34-0.5%2.6912 of 5 stars2.91$19.14 -5.9%11Trending NewsAnalyst Upgrade4.33%MRKMerck & Co., Inc.$86.39-1.4%4.9949 of 5 stars2.29$104.31 20.7%21Positive NewsAnalyst Forecast4.21%PFEPfizer$25.67-2.3%4.9492 of 5 stars2.37$28.41 10.7%19Trending NewsAnalyst ForecastOptions Volume3.88%BMYBristol Myers Squibb$44.55-0.2%4.9862 of 5 stars2.33$57.14 28.3%21Positive News3.77%ZTSZoetis$143.61+0.6%4.8615 of 5 stars2.50$200.88 39.9%10Positive NewsAnalyst Forecast3.77%JAZZJazz Pharmaceuticals$137.78+0.3%4.6218 of 5 stars2.76$178.93 29.9%17Analyst Forecast3.51%CORTCorcept Therapeutics$88.43-2.1%4.8853 of 5 stars2.57$135.25 52.9%7Analyst Forecast2.29%AXSMAxsome Therapeutics$118.71+0.1%4.7811 of 5 stars3.00$177.93 49.9%17Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.53%LGNDLigand Pharmaceuticals$184.49+0.7%3.8857 of 5 stars2.71$176.50 -4.3%7Analyst Forecast1.48%PBHPrestige Consumer Healthcare$63.32+0.7%4.4603 of 5 stars2.43$94.80 49.7%71.37%PRGOPerrigo$21.65-0.1%4.931 of 5 stars2.20$34.00 57.0%5Positive NewsAnalyst Forecast1.31%OGNOrganon & Co.$10.25-3.3%4.7506 of 5 stars2.50$17.33 69.1%6Analyst Forecast1.20%SUPNSupernus Pharmaceuticals$48.00-0.1%3.3565 of 5 stars2.80$51.50 7.3%5Analyst Forecast0.96%TARSTarsus Pharmaceuticals$69.75+1.9%0.7744 of 5 stars2.50$66.67 -4.4%8Analyst Forecast0.77%ANIPANI Pharmaceuticals$91.650.0%3.6261 of 5 stars2.90$97.29 6.1%10Analyst Downgrade0.76%OCULOcular Therapeutix$11.91+3.4%3.9704 of 5 stars2.75$22.63 90.0%12Analyst ForecastInsider Trade0.69%AMRXAmneal Pharmaceuticals$10.48+1.2%2.7895 of 5 stars2.80$12.00 14.5%5Analyst Forecast0.67%HROWHarrow$39.74-5.2%2.9042 of 5 stars2.67$68.50 72.4%9Analyst Forecast0.58%HRMYHarmony Biosciences$26.56-1.8%4.6231 of 5 stars2.91$45.50 71.3%110.57%PCRXPacira BioSciences$23.41-0.9%3.8592 of 5 stars2.43$33.40 42.7%7News CoveragePositive NewsAnalyst Forecast0.55%LQDALiquidia Technologies$24.08+0.2%3.4162 of 5 stars2.70$32.38 34.4%10Positive NewsAnalyst Forecast This page (NYSEARCA:IHE) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
